Oct 8 2018 |
Health Care Enforcement Quarterly Roundup - October 2018 |
McDermott Will & Schulte LLP |
Oct 6 2018 |
The New Jersey Supreme Court’s Latest Decision Affecting Pharmaceutical Multicounty Litigation |
Stark & Stark |
Oct 5 2018 |
MERCOSUR Revised Resolution on Additives for Plastic FCMs in Final Review |
Keller and Heckman LLP |
Oct 5 2018 |
DEA Schedules a FDA-Approved CBD Drug |
McDermott Will & Schulte LLP |
Oct 5 2018 |
Final Opioid Legislation Expands Treatment Options for Medicaid Beneficiaries with Substance Use Disorder |
Mintz |
Oct 5 2018 |
The Week Ahead in the European Parliament – October 5, 2018 |
Covington & Burling LLP |
Oct 5 2018 |
FDA Issues Final Guidance on Medical Device Benefit and Risk Analysis for 510(K)S |
Barnes & Thornburg LLP |
Oct 5 2018 |
Special Ruling Aimed At Restricting NJ Craft Breweries Indefinitely Suspended |
Stark & Stark |
Oct 5 2018 |
FDA Collects Thousands of Pages of Documents in Inspection of JUUL Labs |
Keller and Heckman LLP |
Oct 5 2018 |
UK Government Issues “No Deal” Brexit Notices for the Food & Beverage Sector |
Covington & Burling LLP |
Oct 4 2018 |
Selling CBD Products is Illegal, Ohio Board of Pharmacy Clarifies |
Dinsmore & Shohl LLP |
Oct 4 2018 |
Industry Group Agrees to Stricter Nutrition Criteria for Foods Advertised to Children under 12 |
Keller and Heckman LLP |
Oct 3 2018 |
Delaware Court Finds “Material Adverse Effect” Allows Buyer to Terminate Merger Agreement: Akorn, Inc. v. Fresenius Kabi AG |
Mintz |
Oct 3 2018 |
EPA Releases Working Approach for Identifying Potential Candidate Chemicals for Prioritization under TSCA |
Bergeson & Campbell, P.C. |
Oct 3 2018 |
Cannabis Advertising |
Womble Bond Dickinson (US) LLP |
Oct 3 2018 |
EPA Requests Public Nominations for FIFRA SAP; Requests Independent Scientific Advice on Health and Safety Issues |
Bergeson & Campbell, P.C. |
Oct 3 2018 |
FDA Finds Exposure to Pesticides and Glyphosate in Food Samples Below Federal Limits |
Keller and Heckman LLP |
Oct 2 2018 |
EPA Will Publish SNUR for Carbon Nanomaterial (Generic) |
Bergeson & Campbell, P.C. |
Oct 2 2018 |
U.S. Border Protection Agency Warns: Lifetime Ban Possible for Cannabis Industry Links |
Jackson Lewis P.C. |
Oct 2 2018 |
Blocking Patent Discounts Objective Indicia Of Non-Obviousness |
Foley & Lardner LLP |
Oct 2 2018 |
German Scientific Advisory Body Calls for New EU Legislation on Gene Editing Technology |
Keller and Heckman LLP |
Oct 1 2018 |
FDA Seeks Civil Monetary Penalties Measures to Enforce Compliance with ClinicalTrials.org Requirements |
Epstein Becker & Green, P.C. |
Oct 1 2018 |
Travelers in a Dangerous Time: The Do’s and Don’ts of Crossing the United States Border in the Cannabis Age |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Oct 1 2018 |
Recent Retailer Direct Shipping Opinion Illustrates Stakes in Upcoming Supreme Court Review |
McDermott Will & Schulte LLP |
Oct 1 2018 |
USDA Updates Poultry Line Speed Standards |
Keller and Heckman LLP |
Sep 30 2018 |
The Week Ahead in the European Parliament – September 28, 2018 |
Covington & Burling LLP |
Sep 29 2018 |
EPA Announces its Working Approach for Identifying Chemicals for Prioritization |
Bergeson & Campbell, P.C. |
Sep 28 2018 |
US Supreme Court to Review State Residency Requirements |
McDermott Will & Schulte LLP |
Sep 28 2018 |
FDA Solicits Public Comment on Use of the Names of Dairy Foods in the Labeling of Plant-Based Products |
Keller and Heckman LLP |
Sep 27 2018 |
Marijuana-Based Drug Is Placed On Schedule V of Controlled Substances Act |
Jackson Lewis P.C. |
Sep 27 2018 |
EPA Issues TSCA User Fees Final Rule |
Bergeson & Campbell, P.C. |
Sep 27 2018 |
FDA Issues Policy and Related Draft Guidance on Publicizing List of Retailers in Certain Food Recall Situations |
Keller and Heckman LLP |
Sep 26 2018 |
Oral Argument Held in Deeming Rule Appeal by Nicopure Labs and Right to be Smoke-Free Coalition |
Keller and Heckman LLP |
Sep 26 2018 |
ITIF Petitions FDA to Prohibit Non-GMO Claims on Food Labels |
Keller and Heckman LLP |
Sep 26 2018 |
Tennessee Department of Labor Revises Drug-Free Workplace Program Requirements |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |